US 11389497
Pharmaceutical composition for treating cancer
granted A61KA61K2236/00A61K31/191
Quick answer
US patent 11389497 (Pharmaceutical composition for treating cancer) held by Prime Bio, Inc. expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Prime Bio, Inc.
- Grant date
- Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2236/00, A61K31/191, A61K31/375, A61K36/53